Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 731259Generated: October 30, 2026

Ethanol → HCID 137194578, compound

https://huagongshe.com/reaction/731259

Reaction equation

Participants

RoleNameHCIDCharge
ReactantEthanolHCID 702—
Reactant4-MethylmorpholineHCID 7972—
ReactantSodium ethoxideHCID 2723922—
Reactant1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 2723939—
Reactant2H-1,2,4-Benzothiadiazine-3-acetic acid, 7-[(methylsulfonyl)amino]-, 1,1-dioxideHCID 24858539—
ReactantHCID 57671231HCID 57671231—
SolventAcetic AcidHCID 176—
SolventDimethylformamideHCID 6228—
ProductHCID 137194578HCID 1371945781.7%

Reaction Conditions

Temperature25 °C

Reaction Steps

A solution of (7-methanesulfonylamino-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-3-yl)-acetic acid (prepared as described in Example 1j, 0.100 g, 0.300 mmol) and 2-cyclopentylamino-cyclopentanecarboxylic acid ethyl ester (0.068 g, 0.300 mmol) in N,N-dimethylformamide (1.5 mL) was treated with N-methylmorpholine (63.7 mg, 0.63 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (60.4 mg, 0.315 mmol) and stirred at 25° C. for 4 h. The solvent was removed in vacuo. The crude material was redissolved in ethyl acetate (75 mL) and washed twice with 1.0 M aqueous hydrochloric acid solution (50 mL). The organic layer was then dried over sodium sulfate, filtered and concentrated in vacuo. The crude intermediate was redissolved in ethanol (5 mL) and treated with a 21% w/w solution of sodium ethoxide in ethanol (448 μL, 1.2 mmol) and stirred for 2 h at 60° C. The reaction was allowed to cool to 25° C., treated with glacial acetic acid (0.4 mL), the solvents were removed in vacuo, and the residue was and purified by prep-HPLC [Column Luna 5μ C18 (2) 100 Å AXIA 50×21.2 mm, 5 micron, 30%-90% in 7 min @ 30 mL/min flow rate, 0.05% trifluoroacetic acid in acetonitrile/0.05% trifluoroacetic acid in water] to afford the desired product, cis-N-[3-(1-cyclopentyl-4-hydroxy-2-oxo-2,4a,5,6,7,7a-hexahydro-1H-[1]pyrindin-3-yl)-1,1-dioxo-1,4-dihydro-1λ6-benzo[1,2,4]thiadiazin-7-yl]-methanesulfonamide (2.5 mg, 0.005 mmol, 1.7%), as a white solid. 1H NMR (400 MHz, DMSO-d6) δ: 1.51-2.11 (13H, m), 3.06 (3H, s), 3.84-4.03 (1H, m), 4.52-4.67 (1H, m), 7.49-7.57 (3H, m), 10.17 (1H, s). LC-MS (ESI) calcd for C21H26N4O6S2 494.13, found 495.5 [M+H+].

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07582626B2
Source datasetuspto-grants-2009_09
ORD IDord-70a9574ccd9243dfa7e488dfece91c96
Source noteuspto-grants-2009_09